Device Trial Radar · NCT04695691
A Device Study for the Treatment of Acne
Last checked: Nov 20, 2026Latest source record: Nov 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
104
Actual
Start
Dec 15, 2020
Primary completion
Oct 9, 2021
Study completion Dec 7, 2022
Sponsor
- Lead sponsor
- Cutera Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 5, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
Cutera Laser SystemDevice
Subjects will receive laser treatments
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Treatment SuccessTime frame: 12 weeks post final treatment, up to 24 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Cutera Research Center
Brisbane, California
Blackhawk Plastic Surgery
Danville, California
Center for Dermatology Clinical Research, Inc
Fremont, California
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.